Johns Hopkins Multiple Sclerosis Center receives MS research grant from Progressive Alliance

The Johns Hopkins Multiple Sclerosis Center is the recipient of one of 22 research grants offered to investigators in nine countries by the International Progressive MS Alliance, a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis (MS).

The recipients of the grants in the first round of such funding are to be announced Thursday at a meeting of MS scientists in Boston. Accepting the award for Johns Hopkins will be Peter Calabresi, M.D., director of the Multiple Sclerosis Center.

The funding launches an ambitious program that will invest nearly $30 million over the next five years in finding treatments and solutions for progressive MS. It also will forge international collaborative research networks, which will leverage research already underway and stimulate new research through the alliance’s significant funding programs. For this initial short-term offering, 195 research proposals were received from 22 countries.

“The Johns Hopkins Multiple Sclerosis Center is very excited about receiving this award from the Progressive Alliance, and we are looking forward to initiating this novel clinical trial in progressive MS,” says Calabresi. The center will receive $90,000 now but could receive more from another round of funding. “If this pilot is successful, we would be considered for a much bigger grant,” Calabresi adds.

“The research community’s response to our first call for innovative research proposals has been exceptional, and it speaks to both the unmet need and the galvanizing force of this international initiative,” says Cynthia Zagieboylo, chair of the Alliance’s Executive Committee and president and CEO of the National Multiple Sclerosis Society. “For the first time, MS societies around the globe are funding research together without considering geography to find the answers the progressive MS community urgently needs.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spatial transcriptomics uncovers tissue niches in multiple sclerosis